← Open Payments lookup

KIMBERLY KEENE: Open Payments

NPI 1285004234 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$871 in 27 payments from 7 companies in 2025. Trend: 2023 $1,053 · 2024 $878 · 2025 $871

Food & beverage: $871
CompanyPaymentsAmount
Alkermes, Inc.7$374
Neurocrine BioSciences, Inc.6$189
Janssen Pharmaceuticals, Inc4$93
Otsuka America Pharmaceutical, Inc.4$92
E.R. Squibb & Sons, L.L.C.3$55
Teva Pharmaceuticals USA, Inc.2$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$31

Products named: ARISTADA, INGREZZA, LYBALVI, INVEGA SUSTENNA, ABILIFY ASIMTUFII, COBENFY, CAPLYTA, ABILIFY MAINTENA.

Industry payments across AZ — which companies pay providers there.